• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 
DeviceCross-Seal Suture-Mediated Vascular Closure Device System
Generic NameDevice, hemostasis, vascular
ApplicantTerumo Medical Corporation
265 Davidson Ave.
Suite 320
Somerset, NJ 08873
PMA NumberP210017
Date Received04/29/2021
Decision Date09/26/2023
Product Code MGB 
Advisory Committee Cardiovascular
Clinical TrialsNCT03756558
Expedited Review Granted? No
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
Approval for the Cross-Seal Suture-Mediated Vascular Closure Device System. The device is indicated for the percutaneous delivery of sutures for closing the common femoral artery access site while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional catheterization procedures using 8F to 18F sheaths. The Cross-Seal System is indicated for one access site per leg.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
-
-